Activation of ERK1/2 by MoMuLV-ts1
Induction of apoptosis by ASK1, a mammalian MAPKKK that
activates SAPK/JNK and p38 signaling pathways. Science
275:90–94.
References
Akagi T, Ono H, and Shimotohno K (1996). Expression of
cell-cycle regulatory genes in HTLV-I infected T-cell lines:
Possible involvement of Tax1 in the altered expression of
cyclin D2, p18ink4 and p21waf1/cip1/sdi1. Oncogene 12:
1645–1652.
Iwawaki T, Hosoda A, Okuda T, Kamigori Y, Nomura-
Furuwatari C, Kimata Y, Tsuru A, and Kohno K (2001).
Translational control by the ER transmembrane kinase/
ribonuclease IRE1 under ER stress. Nat Cell Biol 3:158–164.
Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel P
(1995). PD 098059 is a specific inhibitor of the activation of
mitogen-activated protein kinase in vitro and in vivo. J Biol
Chem 270:27489–27494.
Jordan-Sciutto KL, Wang G, Murphy-Corb M, and Wiley CA
(2000). Induction of cell-cycle regulators in simian immuno-
deficiency virus encephalitis. Am J Pathol 157:497–507.
Kaufman RJ (1999). Stress signaling from the lumen of the
endoplasmic reticulum: Coordination of gene transcriptional
and translational controls. Genes Dev 13:1211–1233.
Bhat NR, Zhang P, Lee JC, and Hogan EL (1998). Extracel-
lular signal-regulated kinase and p38 subgroups of mitogen-
activated protein kinases regulate inducible nitric oxide syn-
thase and tumor necrosis factor-alpha gene expression in
endotoxin-stimulated primary glial cultures. J Neurosci 18:
1633- 1641.
Keller D, Zeng X, Li X, Kapoor M, Iordanov MS, Taya Y,
Lozano G, Magun B, and Lu H (1999). The p38MAPK inhibitor
SB203580 alleviates ultraviolet-induced phosphorylation at
serine 389 but not serine 15 and activation of p53. Biochem
Biophys Res Commun 261:464–471.
Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grass-
mann R, Franchini G, and Klotman ME (1996). p53 functional
impairment and high p21 (waf1/cip1) expression in human
T-cell lymphotropic/leukemia virus type I-transformed T cells.
Blood 88:1551–1560.
Kim HT, Qiang W, Wong PKY, and Stoica G (2001). Enhanced
proteolysis of IB␣ and IB proteins in astrocytes by Moloney
murine leukemia virus (MoMuLV)-ts1 infection: A potential
mechanism of NF-B activation. J Neurovirol 7:466–475.
Choe W, Stoica G, Lynn W, and Wong PKY (1998). Neuro-
degeneration induced by MoMuLV-ts1 and increased ex-
pression of Fas and TNF-␣ in the central nervous system.
Brain Res 779:1–8.
Kubbutat MH, Jones SN, and Vousden KH (1997). Regulation
of p53 stability by Mdm2. Nature 387:299–303.
Levine AJ (1997). p53, the cellular gatekeeper for growth and
Chretien F, Boche D, Lorin de la Grandmaison G, Ereau T,
Mikol J, Hurtrel M, Hurtrel B, and Gray F (2000). Progressive
multifocal leukoencephalopathy and oligodendroglioma in a
monkey co-infected by simian immunodeficiency virus and
simian virus 40. Acta Neuropathol (Berl) 100:332–336.
division. Cell 88:323–331.
Lewis TS, Shapiro PS, and Ahn NG (1998). Signal transduction
through MAP kinase cascades. Adv Cancer Res 74:49–139.
Lin YC, Chow CW, Yuen PH, and Wong PKY (1997). Establish-
ment and characterization of conditionally immortalized astro-
cytes to study their interaction with ts1, a neuropathogenic
mutant of Moloney murine leukemia virus. J Neurovirol 3:8–37.
Dhanasekaran N and Reddy EP (1998). Signaling by dual
specificity kinases. Oncogene 17:1447–1455.
Dudley DT, Pang L, Decker SJ, Bridges AJ, and Salteil AR
(1995). A synthetic inhibitor of the mitogen-activated protein
kinase cascade. Proc Natl Acad Sci USA 92:7686–7689.
Liu M, Dhanwada KR, Birt DF, Hecht S, and Pelling JC (1994)
Increase in p53 protein half-life in mouse keratinocytes
following UV-B irradiation. Carcinogenesis 15:1089–1092.
Ehsan A, Fan H, Eagan PA, Siddiqui HA, and Gulley ML
(2000). Accumulation of p53 in infectious mononucleosis
tissues. Hum Pathol 31:1397–1403.
Maki CG, Huibregtse JM, and Howley PM (1996). In vivo
ubiquitination and proteasome-mediated degradation of p53.
Cancer Res 56:2649–2654.
Fuchs SY, Adler V, Pincus MR, and Ronai Z (1998a). MEKK1/
JNK signaling stabilizes and activates p53. Proc Natl Acad
Sci USA 95:10541–10546.
McLean TI and Bachenheimer SL (1999). Activation of c-Jun
N-terminal kinase by herpes simplex virus type 1 enhances
viral replication. J Virol 73:8415–8426.
Fuchs SY, Fried VA, and Ronai Z (1998b). Stress-activated
Miyashita T and Reed JC (1995). Tumor suppressor p53 is a
direct transcriptional activator of the human bax gene. Cell
80:293–299.
kinases regulate protein stability. Oncogene 17:1483–1490.
Gardner MB (1978). Type C viruses of wild mice: Character-
ization and natural history of amphotropic, ecotropic, and
xenotropic MuLV. Curr Top Microbiol Immunol 79:215–259.
Monick MM, Staber JM, Thomas KW, and Hunninghake GW
(2001). Respiratory syncytial virus infection results in activation
of multiple protein kinase C isoforms leading to activation of
mitogen-activated protein kinase. J Immunol 166:2681–2687.
Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer
G, Richman DD, Carson DA, Corbeil J, and Leoni LM (2001). HIV
induces lymphocyte apoptosis by
a
p53-initiated,
mitochondrial-mediated mechanism. FASEB J 15:5–6.
Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F,
and Deppert W (1995). Negative feedback regulation of
wild-type p53 biosynthesis. EMBO J 14:4442–4449.
Giaccia AJ and Kastan MB (1998). The complexity of p53
modulation: Emerging patterns from divergent signals.
Genes Dev 12:2973–2983.
Neary JT, McCarthy M, Kang Y, and Zuniga S (1998).
Mitogenic signaling from P1 and P2 purinergic receptors to
mitogen-activated protein kinase in human fetal astrocyte
cultures. Neurosci Lett 242:159–162.
Haffner R and Oren M (1995). Biochemical properties and
biological effects of p53. Curr Opin Genet Dev 5:84–90.
Haupt Y, Maya R, Kazaz A, and Oren M (1997). Mdm2
promotes the rapid degradation of p53. Nature 387:296–299.
Pariat M, Carillo S, Molinari M, Salvat C, Debussche L,
Bracco L, Milner J, and Piechaczyk M (1997). Proteolysis by
calpains: A possible contribution to degradation of p53. Mol
Cell Biol 17:2806–2815.
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T,
Takagi M, Matsumoto K, Miyazono K, and Gotoh Y (1997).
Laboratory Investigation • June 2002 • Volume 82 • Number 6 701